I. Bingul Et Al. , "Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma," JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.31, no.6, 2017
Bingul, I. Et Al. 2017. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma. JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.31, no.6 .
Bingul, I., Vural, P., Dogru-Abbasoglu, S., Cil, E., & Uysal, M., (2017). Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma. JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.31, no.6.
Bingul, İlknur Et Al. "Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma," JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.31, no.6, 2017
Bingul, İlknur Et Al. "Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma." JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.31, no.6, 2017
Bingul, I. Et Al. (2017) . "Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma." JOURNAL OF CLINICAL LABORATORY ANALYSIS , vol.31, no.6.
@article{article, author={İlknur BİNGÜL Et Al. }, title={Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma}, journal={JOURNAL OF CLINICAL LABORATORY ANALYSIS}, year=2017}